Cost-Effectiveness of Osteoporosis Opportunistic Screening Using Computed Tomography in China

Value Health Reg Issues. 2023 Nov:38:38-44. doi: 10.1016/j.vhri.2023.06.001. Epub 2023 Jul 14.

Abstract

Objectives: Underutilization and insufficient availability of dual-energy X-ray absorptiometry (DXA) in diagnosing osteoporosis in China could be changed by adopting unindicated quantitative computed tomography. We aimed to assess the cost-effectiveness of quantitative computed tomography (QCT) as a screening tool for osteoporosis in China.

Methods: A Markov microsimulation model was developed to assess the long-term costs and quality-adjusted life-years (QALYs) saved associated with 2 examinations as opportunistic screening for osteoporosis in a general population without prior histories of fracture. The diagnostic performance of both examinations was incorporated into the model. In lifetime modeling, opportunistically screened people may face the risk of experiencing hip, vertebral, and wrist fractures depending on their osteoporosis, age, and sex. Model parameters were informed by published literature.

Results: The base-case result showed that QCT was associated with higher costs ($6054 vs $5883) and higher benefits (10.081 vs 10.071 QALYs) in comparison with DXA, making QCT a cost-effective option for opportunistic screening (incremental cost-effectiveness ratio of US $16 430/QALY). Screening with QCT led to fewer fractures over the lifetime simulation: for every 10 000 people screened, 129 fractures (32 hip, 78 vertebral, and 19 wrist fractures) could be avoided because of the early initiation of antiosteoporotic treatment.

Conclusions: Using QCT to screen people for osteoporosis is more cost-effective than standard practice in China, where access to DXA is minimal. This finding could support opportunistic osteoporosis screening using QCT in other countries with similar status.

Keywords: cost-effectiveness analysis; dual-energy X-ray absorptiometry; opportunistic screening; quantitative computed tomography.

MeSH terms

  • China
  • Cost-Benefit Analysis
  • Fractures, Bone* / epidemiology
  • Humans
  • Mass Screening
  • Osteoporosis* / diagnostic imaging
  • Tomography